Global Anti-VEGF Intravitreal Drugs Market Growth 2024-2030
Anti-VEGF intravitreal drugs refer to a class of medications used in ophthalmology to treat various eye conditions characterized by abnormal blood vessel growth and leakage,notably wet age-related macular degeneration(AMD),diabetic retinopathy,and macular edema,which work by blocking VEGF.These medications help reduce the growth of abnormal blood vessels,decrease vascular leakage, and thereby stabilize or improve vision.
The global Anti-VEGF Intravitreal Drugs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Anti-VEGF Intravitreal Drugs Industry Forecast” looks at past sales and reviews total world Anti-VEGF Intravitreal Drugs sales in 2023, providing a comprehensive analysis by region and market sector of projected Anti-VEGF Intravitreal Drugs sales for 2024 through 2030. With Anti-VEGF Intravitreal Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-VEGF Intravitreal Drugs industry.
This Insight Report provides a comprehensive analysis of the global Anti-VEGF Intravitreal Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-VEGF Intravitreal Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-VEGF Intravitreal Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-VEGF Intravitreal Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-VEGF Intravitreal Drugs.
United States market for Anti-VEGF Intravitreal Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Anti-VEGF Intravitreal Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Anti-VEGF Intravitreal Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Anti-VEGF Intravitreal Drugs players cover Roche, Novartis, Biogen, Coherus BioSciences, Regeneron Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-VEGF Intravitreal Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Ranibizumab
Aflibercept
Conbercept
Brolucizumab
Faricimab
Other
Segmentation by Application:
Age-related Macular Degeneration
Diabetic Macular Edema
Retinal Vein Occlusion
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Roche
Novartis
Biogen
Coherus BioSciences
Regeneron Pharmaceuticals
Samsung Bioepis
Biocon Biologics
Qilu Pharma
Chengdu Kanghong Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Anti-VEGF Intravitreal Drugs market?
What factors are driving Anti-VEGF Intravitreal Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-VEGF Intravitreal Drugs market opportunities vary by end market size?
How does Anti-VEGF Intravitreal Drugs break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.